InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (2 ops.)
Insider track record
CFODisclosed buys
4
Disclosed sells
2
T+90 hit rate
14%
T+90 mean return
-25.0%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Booth Andrew, Chief Financial Officer. Officer active across 1 company, notably AbCellera Biologics Inc.. In total, 12 filings have been published. Breakdown: 4 buys · 2 sells. Total volume traded: €52.2m. Activity tracked since 7 June 2021. The latest transaction was filed on 3 June 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
250,000 shares@ US$0.190.0033% mcap0.1% of flowCommon SharesSEC:0001834411-26-000006:0
14,500 shares@ US$6.850.2% of flowCommon SharesSEC:0001209191-23-032484:0
Ideal exit: 20 Feb 2024 (T+270)
50,000 shares@ US$0.190.0% of flowCommon SharesSEC:0001209191-22-062412:0
85,000 shares@ US$5.790.038% mcap0.9% of flowCommon SharesSEC:0001209191-22-029091:0
Ideal exit: 6 Feb 2023 (T+270)
500,000 shares@ US$0.320.3% of flowCommon SharesSEC:0001209191-21-069084
500,000 shares@ US$0.320.011% mcap0.3% of flowCommon SharesSEC:0001209191-21-069084:0
53,500 shares@ US$14.741.3% of flowCommon SharesSEC:0001209191-21-064378
Ideal exit: 8 Aug 2022 (T+270)
53,500 shares@ US$14.740.055% mcap1.3% of flowCommon SharesSEC:0001209191-21-064378:0
Ideal exit: 8 Aug 2022 (T+270)
1,200,000 shares@ US$25.502.01% mcap47.8% of flowCommon SharesSEC:0000899243-21-022988:0
1,200,000 shares@ US$25.5047.7% of flowCommon SharesSEC:0000899243-21-022988
600,000 shares@ US$0.190.0075% mcap0.2% of flowCommon SharesSEC:0000899243-21-022894:0
600,000 shares@ US$0.190.2% of flowCommon SharesSEC:0000899243-21-022894
12 of 12 declarations
About Booth Andrew
Andrew Booth is the Chief Financial Officer of AbCellera Biologics Inc. In this role, he is responsible for the company's financial management, including financial planning, analysis, and strategy. His expertise in finance and resource management contributes to the growth and sustainability of the company. Andrew plays a key role in making strategic decisions that support AbCellera's long-term goals.
